GSK3B and Alzheimer disease: Among AD patients, it was observed that hyperactivation of several proteins, including GSK3β, NMDA-receptor, and BACE-1, could cause deposition of amyloid plaques and/or formation of neurofibrillary tangles, which can lead to deterioration of nerve cells and negatively effects neurotransmission [3].